Thea Pharma rolls out latanoprost ophthalmic solution 0.005% in the US
September 27th 2023Preservative-free Iyuzeh, launched more than 10 years ago, currently is available in 46 countries, mostly under the brand name Monoprost, with about 1.5 million patients treated monthly, according to the company.
EyePod: Transforming the MIGS pipeline into clinical reality
September 26th 2023Peter J. McDonnell, MD, and Neda Shamie, MD, discuss the transformative impact of minimally invasive glaucoma surgery (MIGS) on glaucoma care and its integration with cataract surgery, sharing insights and practical tips for ophthalmologists.
Eyecbetter announces Amy Dixon, PLY (Paralympian), as new Director of Patient Advocacy
September 23rd 2023As a gold medalist with profound vision loss, she will lead advocacy efforts for people with glaucoma that are designed to empower patients to participate actively in their glaucoma treatment journey